1-(benzyloxy)-2,4-dimethylbenzene | 19578-72-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-(benzyloxy)-2,4-dimethylbenzene
• 英文别名: benzyl 2,4-dimethyphenyl ether；benzyl-(2,4-dimethyl-phenyl)-ether；Benzyl-(2,4-dimethyl-phenyl)-aether；4-Benzyloxy-m-xylol；2,4-Dimethyl-1-phenylmethoxybenzene
• CAS: 19578-72-4
• 化学式: C₁₅H₁₆O
• mdl: MFCD20390233
• 分子量: 212.291
• InChiKey: BVDRTEGCZJCYTO-UHFFFAOYSA-N

物化性质

• 沸点：
  186-187 °C(Press: 18 Torr)
• 密度：
  1.0455 g/cm3(Temp: 10 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(benzyloxy)-2,4-dimethylbenzene 生成 2,4,5,7-tetramethyl-9-phenyl-xanthene
  参考文献：
  名称：

  372.分子重排。第三部分 芳基苄基醚的热重排

  摘要：

  DOI：

  10.1039/jr9590001873
• 作为产物：
  描述：

  溴甲苯 、 2,4-二甲基苯酚 在 potassium phosphate 、 四丁基溴化铵 作用下， 以 水 为溶剂， 反应 2.0h， 以99%的产率得到1-(benzyloxy)-2,4-dimethylbenzene
  参考文献：
  名称：

  四丁基溴化铵在温和条件下介导的水中苯酚的苄基化

  摘要：

  在室温下，由四丁基溴化铵（TBAB）介导的苯酚在水中的苯甲酸酯化成功完成仅2小时，从而以良好或优异的收率获得了相应的苄基苯基醚。该方案非常有效，简单，避免了催化剂，反应后易于后处理，尤其是“绿色”。

  DOI：

  10.1016/j.tet.2014.01.004

文献信息

• Tetrabutyl ammonium bromide-mediated benzylation of phenols in water under mild condition
  作者：Hailei Wang、Yuping Ma、Heng Tian、Ajuan Yu、Junbiao Chang、Yangjie Wu

  DOI：10.1016/j.tet.2014.01.004

  日期：2014.4

  Benzylation of phenol was successfully achieved in water under room temperature mediated by tetrabutylammonium bromide (TBAB) for only 2 h affording the corresponding benzyl phenyl ether with good to excellent yields. This protocol is very efficient, simple, avoiding catalysts, easy to work-up after reaction, and especially ‘green’.

  在室温下，由四丁基溴化铵（TBAB）介导的苯酚在水中的苯甲酸酯化成功完成仅2小时，从而以良好或优异的收率获得了相应的苄基苯基醚。该方案非常有效，简单，避免了催化剂，反应后易于后处理，尤其是“绿色”。
• SOLUBLE GUANYLATE CYCLASE ACTIVATORS
  申请人：Tan John Q.

  公开号：US20130210798A1

  公开（公告）日：2013-08-15

  This inventions relates to compounds having the structure Formula I and pharmaceutically acceptable salts thereof which are soluble guanylate cyclase activators. The compounds are useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, pulmonary hypertension, angina pectoris, thromboses, restenosis, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver.

  这项发明涉及具有结构式I的化合物及其可接受的药用盐，这些化合物是可溶性鸟苷酸环化酶激活剂。这些化合物对于治疗或预防心血管疾病、内皮功能障碍、舒张功能障碍、动脉粥样硬化、高血压、肺动脉高压、心绞痛、血栓形成、再狭窄、心肌梗死、中风、心脏功能不全、肺动脉高压、勃起功能障碍、支气管哮喘、慢性肾功能不全、糖尿病或肝硬化方面是有用的。
• N-Phenyloxamide derivatives
  申请人：YAMAGUCHI Youichi

  公开号：US20080249175A1

  公开（公告）日：2008-10-09

  A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): wherein R 1 represents a C 6-10 aryl group; or a C 6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, cyano group, nitro group, a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, a halogenated C 1-6 alkoxy group and a C 1-6 alkylsulfanyl group, R 2 represents a C 6-10 aryl group; or a C 6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, hydroxy group, a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, a halogenated C 1-6 alkoxy group, a C 1-6 alkylsulfanyl group and phenyl group, X represents a single bond or oxygen atom, Z represents a phenylene group or a substituted phenylene group, m represents 0 or 1.

  由以下一般式(I)表示的化合物或其盐，或其水合物或其溶剂合物，具有对纤溶酶原激活酶抑制剂-1（PAI-1）的抑制作用：其中R1表示一个C6-10芳基团；或一个C6-10芳基团，该芳基团取代为从卤原子、氰基、硝基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、卤代C1-6烷氧基和C1-6烷基硫基等组成的组或组合物，R2表示一个C6-10芳基团；或一个C6-10芳基团，该芳基团取代为从卤原子、羟基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、卤代C1-6烷氧基、C1-6烷基硫基和苯基等组成的组或组合物，X表示一个单键或氧原子，Z表示一个苯基或取代苯基，m表示0或1。
• CANCER THERAPY
  申请人：Banerjee Partha

  公开号：US20100130579A1

  公开（公告）日：2010-05-27

  The present invention relates to methods of inducing expression of an epigenetically silenced gene, RASSF1A, in cells, particularly human cells, such as cancer cells. It also relates to methods of treating an individual, prophylactically or therapeutically, for cancer in which RASSF1A is epigenetically silenced.

  本发明涉及诱导细胞中表观遗传学沉默基因RASSF1A表达的方法，特别是人类细胞，如癌细胞。它还涉及治疗个体的方法，预防或治疗RASSF1A表观遗传学沉默引起的癌症。
• N-PHENYLOXAMIDIC ACID DERIVATIVE
  申请人：Institute of Medicinal Molecular Design, Inc.

  公开号：EP2072498A1

  公开（公告）日：2009-06-24

  A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): wherein R1 represents a C6-10 aryl group; or a C6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, cyano group, nitro group, a C1-6 alkyl group, a halogenated C1-6 alkyl group, a C1-6 alkoxy group, a halogenated C1-6 alkoxy group and a C1-6 alkylsulfanyl group, R2 represents a C6-10 aryl group; or a C6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, hydroxy group, a C1-6 alkyl group, a halogenated C1-6 alkyl group, a C1-6 alkoxy group, a halogenated C1-6 alkoxy group, a C1-6 alkylsulfanyl group and phenyl group, X represents a single bond or oxygen atom, Z represents a phenylene group or a substituted phenylene group, m represents 0 or 1.

  由下式通式（I）代表的化合物或其盐或其水合物或其溶液，对纤溶酶原激活物抑制剂-1（PAI-1）具有抑制作用： 其中 R1 代表 C6-10 芳基；或被选自卤素原子、氰基、硝基、C1-6 烷基、卤代 C1-6 烷基、C1-6 烷氧基、卤代 C1-6 烷氧基和 C1-6 烷硫基的一个或多个基团取代的 C6-10 芳基，R2 代表 C6-10 芳基；或被选自卤素原子、羟基、C1-6 烷基、卤代 C1-6 烷基、C1-6 烷氧基、卤代 C1-6 烷氧基、C1-6 烷硫基和苯基的一个或多个基团取代的 C6-10 芳基，X 代表单键或氧原子，Z 代表亚苯基或取代的亚苯基，m 代表 0 或 1。